Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
View/ Open
aag0945_ArticleContent_v3.pdf (17.41Mb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Incio, Joao
McManus, Daniel T.
Suboj, Priya
Pinter, Matthias
Babykutty, Suboj
Chin, Shan M.
Huang, Yuhui
Rahbari, Nuh N.
Roberge, Sylvie
Wang, Dannie
Gomes-Santos, Igor L.
Puchner, Stefan B.
Schlett, Christopher L.
Hoffmman, Udo
Ancukiewicz, Marek
Published Version
https://doi.org/10.1126/scitranslmed.aag0945Metadata
Show full item recordCitation
Incio, Joao, Jennifer A. Ligibel, Daniel T. McManus, Priya Suboj, Keehoon Jung, Kosuke Kawaguchi, Matthias Pinter, et al. 2018. “Obesity Promotes Resistance to Anti-VEGF Therapy in Breast Cancer by up-Regulating IL-6 and Potentially FGF-2.” Science Translational Medicine 10 (432) (March 14): eaag0945. doi:10.1126/scitranslmed.aag0945.Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:42671423
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)